Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Asthma - management

  • Tezepelumab efficacy in patients with severe, uncontrolled asthma and comorbid nasal polyps in NAVIGATOR
    Andrew Menzies-Gow, Jonathan Corren, Elliot Israel, Tobias Welte, Christopher S Ambrose, Bill Cook, Gillian Hunter, Jean-Pierre Llanos-Ackert, Gene Colice
    European Respiratory Journal Sep 2021, 58 (suppl 65) PA876; DOI: 10.1183/13993003.congress-2021.PA876
  • Bronchial thermoplasty upregulates the expression of the glucocorticoid receptor in tissue sections
    Liang Zhou, Lei Fang, Eleni Papakonstantinou, Michael Tamm, Michael Roth, Daiana Stolz
    European Respiratory Journal Sep 2021, 58 (suppl 65) PA545; DOI: 10.1183/13993003.congress-2021.PA545
  • BIOLOGICS SWITCH IN SEVERE EOSINOPHILIC ASTHMA
    Marco Caminati, Gabriella Guarnieri, Diego Bagnasco, Fulvia Chieco Bianchi, Elisiana Carpagnano, Matteo Maule, Beatrice Molena, Girolamo Pelaia, Laura Pini, Gianenrico Senna, Andrea Vianello, Ernesto Crisafulli
    European Respiratory Journal Sep 2021, 58 (suppl 65) PA879; DOI: 10.1183/13993003.congress-2021.PA879
  • Severe asthma and biologic therapies during COVID-19: supporting patients care with home administration of mepolizumab and omalizumab
    Małgorzata Farnik, Karolina Zawada-Drozd, Adam Barczyk
    European Respiratory Journal Sep 2021, 58 (suppl 65) PA882; DOI: 10.1183/13993003.congress-2021.PA882
  • Transitioning from hospital-based biologic care to home care in a severe asthma patient population; a patients’ perspective
    Ryan Robinson, Karl Hunter, Daniella Mclenaghan, Fathimath Shiham, Catherine Lowe, Jane Byrne, Livingstone Chishimba, Seher Zaidi, Gareth Jones, Hannah Joplin, Hassan Burhan
    European Respiratory Journal Sep 2021, 58 (suppl 65) PA888; DOI: 10.1183/13993003.congress-2021.PA888
  • Long-Acting Beta Agonist Asthma Pharmacogenetic Loci Identified in Two Multi-Racial Asthma Clinical Trials
    Victor Ortega, Michelle Daya, Elizabeth Ampleford, Gregory Hawkins, Wendy Moore, Stephen Peters, Kathleen Barnes, Eugene Bleecker, Deborah Meyers
    European Respiratory Journal Sep 2021, 58 (suppl 65) PA886; DOI: 10.1183/13993003.congress-2021.PA886
  • Staphylococcal Enterotoxins sensitization and response of Omalizumab in severe atopic and non atopic asthma
    Nicolas Migueres, Anh Poirot, Nan Zhang, Claus Bachert, Frédéric De Blay
    European Respiratory Journal Sep 2021, 58 (suppl 65) PA881; DOI: 10.1183/13993003.congress-2021.PA881
  • The economic impact recurrent inhaler versus single instructions in asthma and COPD patients
    Esther I. Metting, Jildou Kracht, Richard Dekhuijzen
    European Respiratory Journal Sep 2021, 58 (suppl 65) OA4285; DOI: 10.1183/13993003.congress-2021.OA4285
  • The role of physical rehabilitation in the treatment of bronchial asthma patients
    Mykola Ostrovskyy, Kostiantyn Shvets, Kseniia Ostrovska, Iryna Savelikhina, Oleksandr Varunkiv, Mariana Kulynych-Miskiv, Galyna Korzh, Nadiia Korzh
    European Respiratory Journal Sep 2021, 58 (suppl 65) PA311; DOI: 10.1183/13993003.congress-2021.PA311
  • Cost Effectiveness Comparison of a Dry Powder Inhaler to a Metered Dose Inhaler plus Valved Holding Chamber based on a Functional Respiratory Imaging (FRI) Model
    Mark Nagel, Amanda Bracey, Alison Ellery, Jason Suggett
    European Respiratory Journal Sep 2021, 58 (suppl 65) OA4281; DOI: 10.1183/13993003.congress-2021.OA4281

Pages

  • Previous
  • Next
  • 1
  • …
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • …
  • 203
  • Acute lung injury and critical care (82)
  • Asthma and allergy (635)
  • CF and non-CF bronchiectasis (272)
  • COPD and smoking (902)
  • Epidemiology, occupational and environmental lung disease (212)
  • Genetics (58)
  • Interstitial and orphan lung disease (485)
  • Lung biology and experimental studies (309)
  • Lung cancer (277)
  • Lung imaging (41)
  • Lung structure and function (303)
  • Mechanisms of lung disease (144)
  • Paediatric pulmonology (392)
  • Pulmonary pharmacology and therapeutics (140)
  • Pulmonary vascular disease (509)
  • Respiratory clinical practice (167)
  • Respiratory infections and tuberculosis (949)
  • Sleep medicine (263)
  • Most Read
  • Twitter
Loading
  • The association between SARS-CoV-2 RT-PCR cycle threshold and mortality in a community cohort
  • Pulsus paradoxus
  • Pathogenesis of COVID-19 from a cell biology perspective
  • Global Initiative for Asthma Strategy 2021: executive summary and rationale for key changes
  • Complications of nasal and pharyngeal swabs: a relevant challenge of the COVID-19 pandemic?
More...

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2022 by the European Respiratory Society